Carrier Screening Market to Grow with a CAGR of 14.01% through 2030
Growing prevalence of
genetic diseases, and rising emphasis on early detection and prevention to
drive the carrier screening market in the forecast period, 2026-2030.
According to TechSci Research report, “Carrier
Screening Market - Global Industry Size, Share, Trends, Opportunity,
and Forecast, 2030”, the Global Carrier Screening Market was valued at USD 1.58 billion in 2024 and is expected to reach USD 3.47 billion by 2030 with a CAGR of 14.01% during the forecast period. The increasing
awareness of carrier screening among the population, upcoming new and advanced
technologies in the field of genomics, and rising emphasis on early detection
and prevention are
the primary factors driving the demand for the global carrier screening market.
Heavy investments on research and developments activities by government, increasing
birth rate across the globe, rising focus on personalized medicine, growing
awareness of carrier screening among the population, increasing maternal age are
expected to influence the market demand. The rise in numerous releases and
approvals of new carrier screening tests is also a key factor for increasing
the growth of the carrier screening market, globally.
However, the lack of high complexity testing centers,
regulatory challenges in the field of carrier screening, and existing
diagnostic confidence on conventional screening methods may hamper the growth of
the market in the forecast period.
Browse over XX market
data Figures spread through XX Pages and an in-depth TOC on "Global Carrier Screening Market"
The global carrier screening
market is segmented into type, screening type, technology, indication, end
user, regional distribution and company.
Based on Screening Type, Preconception Carrier Screening is expected to show the fastest growth. This surge is largely driven by the rising emphasis on preventive healthcare and the growing awareness among couples about the importance of identifying genetic risks before conception. Unlike prenatal carrier testing, which is conducted after pregnancy begins, preconception screening offers couples more reproductive options, such as in vitro fertilization (IVF) with preimplantation genetic testing, gamete donation, or informed family planning. This proactive approach is increasingly being promoted by healthcare organizations and fertility specialists worldwide.
Based on the Region, the Asia Pacific region is projected to witness the fastest growth due to rising awareness of genetic disorders, increasing healthcare spending, and government-led initiatives for preventive healthcare. Countries such as China, India, and Japan are experiencing rapid adoption of advanced genetic testing technologies as populations become more aware of the benefits of early detection of inherited conditions. The high birth rate in countries like India, combined with the growing prevalence of genetic disorders such as thalassemia and sickle cell anemia, is driving demand for carrier screening programs. Governments in the region are also stepping up efforts; for example, India’s Ministry of Health has emphasized screening for thalassemia and other hemoglobinopathies as part of its national health mission, while China is investing heavily in precision medicine projects that include genomic testing.
Major operating companies
operating in Global Carrier Screening Market are:
- Eurofins Scientific, Inc.
- Fulgent Genetics, Inc.
- CENTOGENE N.V.
- Invitae Corporation
- Illumina, Inc.
- Gene by Gene, Ltd.
- Laboratory Corporation of America Holdings
- Natera, Inc.
- Myriad Genetics, Inc.
- Quest Diagnostics, Inc
Download Free Sample Report
Customers can also
request for 10% free customization on this report.
“North America region dominates the
market and is expected to maintain its dominance in the coming years
due to the presence of well-established healthcare systems. Also, the wide
access to advanced screening techniques, increasing awareness of using mass
genetic testing programs, presence of various key players, many advances in
genomic medicine, rising government support, and increasing emphasis on
development and research in the region, are expected to propel the global Carrier
Screening market growth” said Mr. Karan Chechi, Research Director of TechSci Research, a research based global management consulting firm.
“Carrier Screening Market
- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented
By Type (Expanded Carrier Screening v/s Targeted Cancer Screening), By
Screening Type (Prenatal Carrier Testing v/s Preconception Carrier Screening),
By Technology (Next Generation Sequencing, Polymerase Chain Reaction,
Microarrays, Others), By Indication (Cystic Fibrosis, Down’s Syndrome,
Thalassemia, Tay-Sachs Disease, Huntington’s Disease, Sickle Cell Anemia,
Others), By End User (Hospitals & Clinics, Reference Laboratories, Others), By Region and Competition,”, has evaluated the future growth potential of global carrier
screening and provides statistics &
information on market size, structure, and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in global carrier screening market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com